Europe Active Pharmaceutical Ingredients (API) 麻豆原创 2021-2027 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity

You are here: 麻豆原创 Catalog Pharma & Healthcare Research & Development (Pharma & Healthcare) Pharmaceutical Manufacturing IT & eHealth

Europe Active Pharmaceutical Ingredients (API) 麻豆原创 2021-2027 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity

麻豆原创 Research Report Summary

Europe Active Pharmaceutical Ingredients (API) 麻豆原创 2021-2027 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity report is published on February 26, 2021 and has 167 pages in it. This market research report provides information about Research & Development (Pharma & Healthcare), Pharmaceutical Manufacturing, IT & eHealth, Pharma & Healthcare industry. It covers Europe market data and forecasts. It is priced starting at USD 2,480.00 for Single User License (PDF) which allows one person to use this report.

Please read the description and table of contents of this research report given below to check whether it meets your research requirements. If not, then please do not hesitate to contact us using "Report Enquiry" form given below. We can customize this research report or suggest a new fully customized market research report to meet your research goals and data requirements.

Europe Active Pharmaceutical Ingredients (API) 麻豆原创 2021-2027 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity

Printer version

Send by email

Publication ID:听

GRM0221039

Publication Date:听

February 26, 2021

笔补驳别蝉:听

167

笔耻产濒颈蝉丑别谤:听

Grace 麻豆原创 Data

颁辞耻苍迟谤颈别蝉:听

Europe

USD 2,480.00

Pay By Invoice

If you wish to purchase this report using bank/wire transfer against an invoice, please fill your details using request invoice form given below.

Globally Trusted Brand

We help executives from firms听to Start-ups听with their market research needs thus听we can help you too.听

Secure Checkout

You can shop confidently as your online payments are processed using PCI DSS compliant secure payment gateways on our website.

Frequently Asked Questions

If you have any pre-sales听questions related to this report please let us know using the "Report Enquiry" form below. This will help us provide you听with answers听so that you can purchase with confidence. If you wish to read about frequently asked questions by our customers please visit our .

Tabs

Description

Europe active pharmaceutical ingredients (API) market accounted for $45.77 billion in 2020 and will grow by 7.5% annually over 2020-2027 the rising need for medicine and pharmaceutical agents amid the COVID-19 pandemic.
Highlighted with 100 tables and 69 figures, this 167-page report 鈥淓urope Active Pharmaceutical Ingredients (API) 麻豆原创 2021-2027 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire Europe API market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2020 and provides forecast from 2021 till 2027 with 2020 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
鈥� 麻豆原创 Structure
鈥� Growth Drivers
鈥� Restraints and Challenges
鈥� Emerging Product Trends & 麻豆原创 Opportunities
鈥� Porter鈥檚 Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe API market in every aspect of the classification from perspectives of Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Country.

Based on Synthesis, the Europe market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.
Synthetic API
鈥� Branded Synthetic API
鈥� Generic Synthetic API
Biotech API by Drug Type:
鈥� Monoclonal Antibodies
鈥� Recombinant Proteins
鈥� Vaccines
鈥� Other Biotech APIs
Biotech API by Customer Base:
鈥� Innovative Biologic API
鈥� Generic Biosimilar API
Biotech API by Expression Technology:
鈥� Mammalian Expression
鈥� Microbial Expression
鈥� Yeast Expression
鈥� Insect Expression
鈥� Other Expression Technologies
HPAPI
鈥� Branded HPAPI
鈥� Generic HPAPI

Based on Manufacturing Process, the Europe market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.
Captive Manufacturing
鈥� Branded Captive API
鈥� Generic Captive API
Merchant Manufacturing by Drug Type:
鈥� Branded Merchant API
鈥� Generic Merchant API
Merchant Manufacturing by Drug Synthesis:
鈥� Merchant Synthetic API
鈥� Merchant Biotech API

Based on Therapeutic Application, the Europe market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.
鈥� Infectious Diseases
鈥� Oncology
鈥� Ophthalmology
鈥� Cardiovascular Disorders
鈥� Central Nervous System
鈥� Pulmonary Disorders
鈥� Orthopedics
鈥� Other Applications

Based on Drug Type, the Europe market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.
鈥� Branded Prescription Drugs
鈥� Generic Prescription Drugs
鈥� OTC Drugs

Geographically, the following national/local markets are fully investigated:
鈥� Germany
鈥� UK
鈥� France
鈥� Spain
鈥� Italy
鈥� Russia
鈥� Rest of Europe (further segmented into Netherlands, Switzerland, Turkey, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue are available for 2017-2027. The breakdown of key national markets by Synthesis, Manufacturing Process, and Therapeutic Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Europe API market are assayed quantitatively and qualitatively through GMD鈥檚 Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
AbbVie Inc.
Astrazeneca
Aurobindo Pharma Ltd.
BASF
Bayer AG
Boehringer Ingelheim
Dr. Reddy's Laboratories
F. Hoffmann-La Roche
GlaxoSmithKline plc
Lonza Group
Lupin Limited
Merck & Co., Inc.
Mylan NV
Novartis International AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table of Contents

1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of 麻豆原创 Research Methodology 13
1.2.2 麻豆原创 Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 16
1.2.6 麻豆原创 Size/Share Estimation 17
1.2.7 Research Limitations 18
1.3 Executive Summary 19
2 麻豆原创 Overview and Dynamics 21
2.1 麻豆原创 Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the 麻豆原创 25
2.2 Major Growth Drivers 27
2.3 麻豆原创 Restraints and Challenges 32
2.4 Emerging Opportunities and 麻豆原创 Trends 35
2.5 Porter鈥檚 Fiver Forces Analysis 39
3 Segmentation of Europe 麻豆原创 by Synthesis 43
3.1 麻豆原创 Overview by Synthesis 43
3.2 Synthetic API 45
3.2.1 Branded Synthetic API 46
3.2.2 Generic Synthetic API 47
3.3 Biotech API 48
3.3.1 Biotech API by Drug Type 49
3.3.1.1 Monoclonal Antibodies 50
3.3.1.2 Recombinant Proteins 51
3.3.1.3 Vaccines 52
3.3.1.4 Other Biotech APIs 53
3.3.2 Biotech API by Customer Base 54
3.3.2.1 Innovative Biologic API 55
3.3.2.2 Generic Biosimilar API 56
3.3.3 Biotech API by Expression Technology 57
3.3.3.1 Mammalian Expression 58
3.3.3.2 Microbial Expression 59
3.3.3.3 Yeast Expression 60
3.3.3.4 Insect Expression 61
3.3.3.5 Other Expression Technologies 62
3.4 HPAPI 63
3.4.1 Branded HPAPI 64
3.4.2 Generic HPAPI 65
4 Segmentation of Europe 麻豆原创 by Manufacturing Process 66
4.1 麻豆原创 Overview by Manufacturing Process 66
4.2 Captive Manufacturing 68
4.2.1 Branded Captive API 69
4.2.2 Generic Captive API 70
4.3 Merchant Manufacturing 71
4.3.1 Merchant Manufacturing by Drug Type 72
4.3.1.1 Branded Merchant API 73
4.3.1.2 Generic Merchant API 74
4.3.2 Merchant Manufacturing by Drug Synthesis 75
4.3.2.1 Merchant Synthetic API 76
4.3.2.2 Merchant Biotech API 77
5 Segmentation of Europe 麻豆原创 by Therapeutic Application 78
5.1 麻豆原创 Overview by Therapeutic Application 78
5.2 Infectious Diseases 80
5.3 Oncology 81
5.4 Ophthalmology 82
5.5 Cardiovascular Disorders 83
5.6 Central Nervous System 84
5.7 Pulmonary Disorders 85
5.8 Orthopedics 86
5.9 Other Applications 87
6 Segmentation of Europe 麻豆原创 by Drug Type 88
6.1 麻豆原创 Overview by Drug Type 88
6.2 Branded Prescription Drugs 90
6.3 Generic Prescription Drugs 91
6.4 OTC Drugs 92
7 European 麻豆原创 2020-2027 by Country 93
7.1 Overview of European 麻豆原创 93
7.2 UK 96
7.3 France 98
7.4 Germany 100
7.5 Spain 102
7.6 Italy 104
7.7 Russia 106
7.8 Rest of European 麻豆原创 108
8 Competitive Landscape 110
8.1 Overview of Key Vendors 110
8.2 New Product Launch, Partnership, Investment, and M&A 113
8.3 Company Profiles 114
AbbVie Inc. 114
Astrazeneca 116
Aurobindo Pharma Ltd. 119
BASF 121
Bayer AG 124
Boehringer Ingelheim 126
Dr. Reddy's Laboratories 130
F. Hoffmann-La Roche 132
GlaxoSmithKline plc 134
Lonza Group 138
Lupin Limited 142
Merck & Co., Inc. 144
Mylan NV 146
Novartis International AG 148
Pfizer Inc. 150
Sanofi 154
Sun Pharmaceutical Industries Ltd. 156
Teva Pharmaceutical Industries Ltd. 158
9 Investing in Europe 麻豆原创: Risk Assessment and Management 161
9.1 Risk Evaluation of Europe 麻豆原创 161
9.2 Critical Success Factors (CSFs) 164
Related Reports and Products 167

Companies Covered

Key Players (this may not be a complete list and extra companies can be added upon request):
AbbVie Inc.
Astrazeneca
Aurobindo Pharma Ltd.
BASF
Bayer AG
Boehringer Ingelheim
Dr. Reddy's Laboratories
F. Hoffmann-La Roche
GlaxoSmithKline plc
Lonza Group
Lupin Limited
Merck & Co., Inc.
Mylan NV
Novartis International AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.

Report License Types

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Enquiry / Request Invoice

Report Inquiry

Do you have more questions related to this market research report after going through the description and table of contents?

We are here to help. Please use the form given below to let us know your questions related to this report.

Kindly use your official email address and contact number to ensure speedy response.

First Name *

Last Name *

Company *

Email Address *

Phone (Including International Code) *

Report Title *

Do you need invoice for purchasing this report? *

Address 1

Address 2

City/Town

Postal/Zip Code

Country

License Type

Your Inquiry *

CAPTCHA

This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Research & Development (Pharma & Healthcare)

Pharmaceutical Manufacturing

IT & eHealth

Pharma & Healthcare

*Please note that the report cover image shown above is for representation purpose only. Actual report cover may vary.

听

Related 麻豆原创 Research Reports

Publication	Price
Global Retinol-binding Protein Immunoturbidimetric Assay Diagnostic Reagent 麻豆原创 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030 According to this latest study, the global Retinol-binding Protein Immunoturbidimetric Assay Diagnostic Reagent market size was valued at US$ xx million in 2023 and is forecast to a readjusted size of USD xx million by 2030 with a CAGR of xx% during review period. This report is a detailed and comprehensive analysis for global Retinol-binding Protein Immunoturbidimetric Assay Diagnostic Reagent market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided. Key Features: Global Retinol-binding Protein ...Read more	USD 3,480.00
Global Preventive Vaccines 麻豆原创 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Region: Trend Forecast and Growth Opportunity Global preventive vaccines market will reach $120.07 billion by 2032, growing by 6.4% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines such as COVID-19 vaccines, and the increasing healthcare expenditure. Highlighted with 111 tables and 87 figures, this 211-page report 鈥淕lobal Preventive Vaccines 麻豆原创 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Region: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire global preventive vaccines market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till...Read more	USD 3,200.00
North America Preventive Vaccines 麻豆原创 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity North America preventive vaccines market is projected to grow by 6.3% annually in the forecast period and reach $46.90 billion by 2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines such as COVID-19 vaccines, and the increasing healthcare expenditure. Highlighted with 52 tables and 51 figures, this 132-page report 鈥淣orth America Preventive Vaccines 麻豆原创 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire North America preventive vaccines market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022...Read more	USD 2,600.00
Europe Preventive Vaccines 麻豆原创 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity Europe preventive vaccines market was valued at $18.02 billion in 2022 and will grow by 5.1% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines such as COVID-19 vaccines, and the increasing healthcare expenditure. Highlighted with 62 tables and 55 figures, this 142-page report 鈥淓urope Preventive Vaccines 麻豆原创 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire Europe preventive vaccines market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023...Read more	USD 2,600.00
Asia Pacific Preventive Vaccines 麻豆原创 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity Asia Pacific preventive vaccines market will grow by 7.9% annually with a total addressable market cap of $217.46 billion over 2023-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines such as COVID-19 vaccines, and the increasing healthcare expenditure. Highlighted with 59 tables and 54 figures, this 141-page report 鈥淎sia Pacific Preventive Vaccines 麻豆原创 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire Asia Pacific preventive vaccines market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022...Read more	USD 2,600.00

Clients Who Trust Us

Need tailor made market research solution? We can help you with that too.

Contact Us

About Us

At 麻豆原创 we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer鈥檚 needs, be it custom research or syndicated research reports.

Contact Us

麻豆原创 Research Reports, Inc
16192 Coastal Hwy
Lewes, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

Latest Blog Posts

Stay Connected

Disclaimer: 麻豆原创 has no affiliation to, and is not associated with any other website(s) or organization(s). We offer syndicated research reports (like country analysis, SWOT analysis, competitive intelligence, industry reports, company reports and market analysis & trends reports) and custom market research from our website 麻豆原创ResearchReports.com only.

If you are looking for a market research solution for your research requirements, please begin your search using the search box on top of this page or use our chat system to speak to our market research consultants or directly write to us.

麻豆原创